Author:
Chang Susan M., ,Wen Patrick,Cloughesy Timothy,Greenberg Harry,Schiff David,Conrad Charles,Fink Karen,Robins H. Ian,De Angelis Lisa,Raizer Jeffrey,Hess Kenneth,Aldape Ken,Lamborn Kathleen R.,Kuhn John,Dancey Janet,Prados Michael D.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference21 articles.
1. Knobbe CB, Merlo A, Reifenberger G: Pten signaling in gliomas. Neuro-oncol 4: 196–211, 2002
2. Sasaki H, Zlatescu MC, Betensky RA, Ino Y, Cairncross JG, Louis DN: PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol 159: 359–367, 2001
3. Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong YK, Yung WK, Steck PA: Differential expression of MMAC/PTEN in glioblastoma multiforme: Relationship to localization and prognosis. Cancer Res 59: 1820–1824, 1999
4. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, O’Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB: PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 93: 1246–1256, 2001
5. Hidalgo M, Rowinsky EK: The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19: 6680–6686, 2000
Cited by
364 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献